182 related articles for article (PubMed ID: 37988195)
21. Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma.
Duan X; Cheng X; Yin X; Ke Z; Song J
Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1535-1547. PubMed ID: 34218307
[TBL] [Abstract][Full Text] [Related]
22. Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
Chuang YH; Lin CY; Lee JC; Lee CH; Liu CL; Huang SH; Lee JY; Lai WS; Yang JM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685875
[TBL] [Abstract][Full Text] [Related]
23. Cancer associated fibroblast derived gene signature determines cancer subtypes and prognostic model construction in head and neck squamous cell carcinomas.
Wu S; Huang C; Su L; Wong PP; Huang Y; Chen R; Lin P; Ye Y; Song P; Han P; Huang X
Cancer Med; 2023 Mar; 12(5):6388-6400. PubMed ID: 36404634
[TBL] [Abstract][Full Text] [Related]
24. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation.
Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K
Front Immunol; 2023; 14():1190678. PubMed ID: 37691922
[TBL] [Abstract][Full Text] [Related]
25. Relationships of Ferroptosis and Pyroptosis-Related Genes with Clinical Prognosis and Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Yu J; Chen Y; Pan X; Wen W
Oxid Med Cell Longev; 2022; 2022():3713929. PubMed ID: 36246400
[TBL] [Abstract][Full Text] [Related]
26. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
Front Genet; 2022; 13():947551. PubMed ID: 35938003
[No Abstract] [Full Text] [Related]
27. Construction of a hypoxia-derived gene model to predict the prognosis and therapeutic response of head and neck squamous cell carcinoma.
Wang H; Zheng L
Sci Rep; 2022 Aug; 12(1):13538. PubMed ID: 35945448
[TBL] [Abstract][Full Text] [Related]
28. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
29. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
30. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
31. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
33. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X
Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630
[TBL] [Abstract][Full Text] [Related]
34. Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer.
Feng B; Shen Y; Pastor Hostench X; Bieg M; Plath M; Ishaque N; Eils R; Freier K; Weichert W; Zaoui K; Hess J
Clin Cancer Res; 2020 Jul; 26(14):3616-3628. PubMed ID: 32161122
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
36. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
37. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
Qiang W; Dai Y; Xing X; Sun X
Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
[TBL] [Abstract][Full Text] [Related]
38. Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts.
Xue H; Sun Q; Zhang H; Huang H; Xue H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):156. PubMed ID: 38526631
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
40. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma.
Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X
Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
